Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3570 publications
French recommendations from the AFU Cancer Committee for prostate cancer 2025 Summary of changes.
Journal: The French journal of urology
Published: October 06, 2025
PARP inhibitors (poly-ADP-ribose polymerase) : newcomers in the management of prostate cancers
Journal: Revue medicale de Liege
Published: September 11, 2025
A Phase 1 study of abemaciclib plus abiraterone in Japanese patients with metastatic castration-resistant prostate cancer.
Journal: Journal of chemotherapy (Florence, Italy)
Published: September 09, 2025
Low-Dose Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Journal: JCO global oncology
Published: September 03, 2025
Canine aldo-keto reductase 1C3 (AKR1C3/PGFS) exhibits 17β/20α-hydroxysteroid dehydrogenase activity and is inhibited by trilostane.
Journal: The Journal of steroid biochemistry and molecular biology
Published: August 25, 2025
Severe Presentation of De Novo Type II Diabetes in Abiraterone and Prednisone Therapy.
Journal: Cureus
Published: August 11, 2025
Comparative effectiveness and safety of enzalutamide versus abiraterone in patients with metastatic castration-resistant prostate cancer: a nationwide registry-based cohort study from Taiwan.
Journal: Journal of cancer research and clinical oncology
Published: August 07, 2025
The Prognostic Roles of Systemic Inflammatory Markers Before Abiraterone or Enzalutamide Therapy in Metastatic Castration-Resistant Prostate Cancer.
Journal: Journal of clinical medicine
Published: August 03, 2025
Comment on: "Association between major cardiovascular events and abiraterone acetate compared to enzalutamide in patients with metastatic castration-resistant prostate cancer: a post hoc analysis of the EVADE study" : Name of authors.
Journal: World journal of urology
Published: August 02, 2025
Adjusting for abiraterone-prednisone cross-over in de novo metastatic castration-sensitive prostate cancer: a post-hoc analysis of the PEACE-1 trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 17, 2025
Last Updated: 10/31/2025